Alphatec Holdings, Inc. (FRA:L1Z1)

Market Cap	1.85B +18.5%
Revenue (ttm)	620.49M +27.1%
Net Income	-132.07M
EPS	-0.89
Shares Out	n/a
PE Ratio	n/a
Forward PE	82.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	5
Open	12.03
Previous Close	12.43
Day's Range	12.03 - 12.03
52-Week Range	8.15 - 19.28
Beta	n/a
RSI	26.99
Earnings Date	Feb 24, 2026

About Alphatec Holdings

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1990
• Employees: 867
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: L1Z1

Financial Performance

In 2024, Alphatec Holdings's revenue was $611.56 million, an increase of 26.81% compared to the previous year's $482.26 million. Losses were -$162.12 million, -13.14% less than in 2023.

Financial numbers in USD